✦ LIBER ✦
Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progression
✍ Scribed by Jatin Shah; Joan Bladé; Pieter Sonneveld; Jean-Luc Harousseau; Keith Lantz; Anil Londhe; Colin Lowery; Robert Z. Orlowski
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 130 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.